Brief: Outlook Therapeutics Inc - Enters Securities Purchase Agreement With Avondale Capital
31/01/2025 23:30
Outlook Therapeutics Inc OTLK.O :
* OUTLOOK THERAPEUTICS INC - ENTERS SECURITIES PURCHASE
AGREEMENT
WITH AVONDALE CAPITAL
* OUTLOOK THERAPEUTICS INC - ISSUES UNSECURED CONVERTIBLE
PROMISSORY NOTE OF $33.1 MILLION
Source text: ID:n0001104659-25-008146
Further company coverage: OTLK.O
Recent news on Outlook Therapeutics
See all newsBrief: Outlook Therapeutics Appoints Kevin Lundquist As Chief Financial Officer As It Prepares For U.S. Commercial Launch Of Lytenava™
Outlook Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Outlook Therapeutics Q3 net loss narrows slightly as costs drop
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce